Your cart is empty

Continue shopping

Breathe with a peace of mind

COVID-19 & the FDA on Air Purifiers

COVID-19 the FDA and Air Purifiers


While TRACS has not tested on SARS-CoV-2 specifically, TRACS devices do meet the performance criteria recommended by the FDA guidelines for use in reducing exposure to SARS-CoV-2 in healthcare settings. 


No air purifier can promise to prevent human beings from getting a virus. We strongly recommend you review information provided by the government for information and resources related to COVD-19.



  • SARS-CoV-2 is a type of coronavirus that causes COVID-19.
  • The FDA believes air purifiers with technology known to eliminate coronaviruses existing prior to COVID-19 may help reduce the risk of SARS-CoV-2 exposure. 
  • TRACS® has UV-C technology known to eliminate airborne coronaviruses but makes no claims to SARS-CoV-2 specifically. 
  • The FDA wants to make sure air purifiers that might reduce the risk of SARS-CoV-2 exposure are marketing properly.



Click Here: FDA Enforcement Policy for Sterilizers, Disinfectant Devices, and Air Purifiers During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency



"FDA believes that certain sterilizers, disinfectant devices, and air purifiers falling within the scope of this guidance may help reduce this risk of viral exposure based on our current understanding of these devices and SARS-CoV-2."

"Coronaviruses are RNA viruses enveloped in a lipid bilayer. SARS-CoV-2 is a type of coronavirus. As depicted in Figure 1, lipid viruses are the least resistant microorganisms on the scale of descending order of resistance to germicidal chemicals. Because sterilization processes render devices free from viable microorganisms including bacterial spores, and because disinfection kills most recognized pathogenic microorganisms, it can generally be inferred that sterilization and disinfection should minimize the viability of SARS-CoV-2 (as one of the least resistant microorganisms) on surfaces and in the air in confined spaces.





You have successfully subscribed!